Welcome to the National Institute for Health and Clinical Excellence
NICE is an independent organisation responsible for providing national guidance on promoting good health and preventing and treating ill health.
Using guidance
NICE helps health professionals implement our guidance by providing tools such as cost templates, audit criteria and slide sets.
Get involved
-
Sacrocolpopexy using mesh for vaginal vault prolapse repair (interventional procedure consultation)
-
Management of long-term sickness absence and incapacity for work: consultation on the draft guidance
-
Promoting physical activity for children (consultation on the draft guidance)
Latest guidance
-
Familial hypercholesterolaemia
-
Macular degeneration (age-related) - ranibizumab and pegaptanib
-
Pregnancy (rhesus negative women) - routine anti-D (review)
-
Hepatitis B - telbivudine
In focus
Measuring effectiveness and cost effectiveness: the QALY
With the rapid advances in modern medicine, most people accept that no publicly funded healthcare system, including the NHS, can possibly pay for every new medical treatment which becomes available. The enormous costs involved mean that choices have to be made.
Latest news
-
New NICE guidelines are set to reduce premature deaths in people who have inherited high cholesterol
27 Aug 2008
-
NICE issues final guidance on the use of ranibizumab and pegaptanib for the treatment of age-related macular degeneration
27 Aug 2008
-
NICE/NPSA issues patient safety solution guidance to reduce the risk of pneumonia in patients on a ventilator
27 Aug 2008
